New registry aims to unlock BRCA pancreatic cancer mystery

NCT ID NCT01983410

First seen Jan 07, 2026 · Last updated May 18, 2026 · Updated 18 times

Summary

This study is building a registry (a database) of people with BRCA or PALB2 gene mutations who have pancreatic cancer. The goal is to collect information and biological samples to help researchers learn why this cancer develops in some gene carriers. Up to 600 participants, including relatives, will be enrolled. No new treatments are being tested; this is purely for gathering knowledge.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Abramson Cancer Center at University of Pennsylvania Medical Center

    Philadelphia, Pennsylvania, 19104-4283, United States

  • Cold Springs Harbor Laboratory (Specimen Analysis)

    Cold Spring Harbor, New York, 11724, United States

  • Memorial Sloan Kettering Basking Ridge

    Basking Ridge, New Jersey, 07920, United States

  • Memorial Sloan Kettering Bergen

    Montvale, New Jersey, 07645, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Memorial Sloan Kettering Commack

    Commack, New York, 11725, United States

  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering Nassau

    Uniondale, New York, 11553, United States

  • Memorial Sloan Kettering Westchester

    Harrison, New York, 10604, United States

  • Shaare Zedek Medical Center

    Jerusalem, Israel

  • Sheba Medical Center

    Tel Litwinsky, Israel

  • Weill Cornell Medical College (Specimen Analysis)

    New York, New York, United States

  • Weizmann Institute of Science (Specimen Analysis)

    Rehovot, Israel

Conditions

Explore the condition pages connected to this study.